Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Chubb
McKinsey
Deloitte
Harvard Business School
Argus Health
Merck
Teva

Generated: January 24, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Amatuximab

« Back to Dashboard

US Patents for Amatuximab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Amatuximab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Amatuximab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Amatuximab ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Amatuximab ➤ Sign Up Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up
Amatuximab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Amatuximab ➤ Sign Up Anti-CD324 monoclonal antibodies and uses thereof ABBVIE STEMCENTRX LLC (North Chicago, IL) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Amatuximab

Drugname Country Document Number Estimated Expiration Related US Patent
Amatuximab Canada 2900764 2033-02-08 ➤ Sign Up
Amatuximab European Patent Office 2954056 2033-02-08 ➤ Sign Up
Amatuximab Hong Kong 1218930 2033-02-08 ➤ Sign Up
Amatuximab Japan 2016509014 2033-02-08 ➤ Sign Up
Amatuximab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Sign Up
Amatuximab Australia 2012294673 2031-08-05 ➤ Sign Up
Amatuximab Canada 2842492 2031-08-05 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Cerilliant
McKesson
Harvard Business School
Baxter
Federal Trade Commission
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.